Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 7, 2026, The Clorox Company (CLX) has a Wall Street consensus price target of $105.50, based on estimates from 28 covering analysts. With the stock currently trading at $90.01, this represents a potential upside of +17.2%. The company has a market capitalization of $10.88B.
Analyst price targets range from a low of $83.00 to a high of $139.00, representing a 53% spread in expectations. The median target of $103.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 4 analysts rating the stock as a Buy or Strong Buy,19 rating it Hold, and 5 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CLX trades at a trailing P/E of 13.8x and forward P/E of 15.3x. Analysts expect EPS to grow -5.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $83.83, with bear and bull scenarios of $33.28 and $82.65 respectively. Model confidence stands at 59/100, reflecting moderate uncertainty in projections.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Walmart Inc..
Start ComparisonQuick answers to the most common questions about buying CLX stock.
The Clorox Company (CLX) has a consensus 12-month price target of $105.5, implying 17.2% upside from $90.01. The 28 analysts covering CLX see moderate appreciation potential.
CLX has a consensus rating of "Hold" based on 28 Wall Street analysts. The rating breakdown is leaning bearish, with 5 Sell/Strong Sell ratings. The consensus 12-month price target of $105.5 implies 17.2% upside from current levels.
With a forward P/E of 15.3438x, CLX trades at a relatively low valuation. The consensus target of $105.5 implies 17.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $139 for CLX, while the most conservative target is $83. The consensus of $105.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $83 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLX is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 19 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLX stock forecast based on 28 Wall Street analysts shows a consensus price target of $105.5, with estimates ranging from $83 (bear case) to $139 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $84, with bear/bull scenarios of $33/$83.
Our quantitative valuation model calculates CLX's fair value at $84 (base case), with a bear case of $33 and bull case of $83. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 59/100.
CLX trades at a forward P/E ratio of 15.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 13.8x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on CLX, with a "Hold" consensus rating and $105.5 price target (17.2% upside). 4 of 28 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLX analyst price targets range from $83 to $139, a 53% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $105.5 consensus represents the middle ground. Our model's $33-$83 range provides an independent fundamental perspective.